The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness, hospitalizations, and death. The complex and multifaceted pathophysiology of life-threatening COVID-19 illness including viral mediated organ damage, cytokine storm, and thrombosis warrants early interventions to address all components of the devastating illness. In countries where therapeutic nihilism is prevalent, patients endure escalating symptoms and without early treatment can succumb to delayed in-hospital care and death. Prompt early initiation of sequenced multidrug therapy (SMDT) is a widely and currently available solution to stem the tide of hospitalizations and death. But does it make any difference?
Yes if u have taking proper care at begining chances are better to recover fast
COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues. Treating people early in the course of infection with SARS-CoV-2, the virus that causes COVID-19, would speed their recovery, reduce the likelihood that they develop severe outcomes, and reduce demand on the healthcare system, they write.
In patients with a poor prognosis, early antiviral therapy may stop the progression of the disease.
Please see the link:
Article Early antiviral treatment contributes to alleviate the sever...
Yes if u have taking proper care at begining chances are better to recover fast
- Badges
- Science topic
- Similar topics
- Biological Science
- Microbiology
- Virology
- Virus